INS and hematocrit: Many other conditions have been identified such as an increased risk of T2D [11,46,47] and IR with a decreased insulin-stimulated glucose uptake [48]; high death rates from IHD [49,50]; higher risk of developing MS [51-53]; CVD and HT independently of genetic factors, shared familial environment, and risk factors for HT in adulthood, including body mass index [54-57]; dyslipidemia with an atherogenic lipid profile [58-60] and obesity [61,62].